|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 4 of 21 found articles
| Title: |
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial |
| Author: |
Reck, Martin Mok, Tony S K Nishio, Makoto Jotte, Robert M Cappuzzo, Federico Orlandi, Francisco Stroyakovskiy, Daniil Nogami, Naoyuki RodrÃguez-Abreu, Delvys Moro-Sibilot, Denis Thomas, Christian A Barlesi, Fabrice Finley, Gene Lee, Anthony Coleman, Shelley Deng, Yu Kowanetz, Marcin Shankar, Geetha Lin, Wei Socinski, Mark A |
| Appeared in: |
Lancet respiratory medicine |
| Paging: | Volume 7 (2019) nr. 5 pages 387-401 |
| Year: |
2019 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 4 of 21 found articles
| << previous | next >> |